Apr 27 |
Biogen Inc. (NASDAQ:BIIB) Just Released Its First-Quarter Earnings: Here's What Analysts Think
|
Apr 26 |
Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates
|
Apr 26 |
The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
|
Apr 26 |
Decoding Biogen Inc (BIIB): A Strategic SWOT Insight
|
Apr 25 |
Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®
|
Apr 25 |
Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX
|
Apr 25 |
Biogen Inc. (NASDAQ:BIIB) Q1 2024 Earnings Call Transcript
|
Apr 25 |
Shareholders 30% loss in Biogen (NASDAQ:BIIB) partly attributable to the company's decline in earnings over past year
|
Apr 25 |
For Beaten-Down Maker of Alzheimer’s Drug, Good Enough Will Do
|
Apr 25 |
Q1 2024 Biogen Inc Earnings Call
|